End-of-day quote
Korea S.E.
23:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
6,270
KRW
|
-0.48%
|
|
-0.48%
|
-1.42%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
76,576
|
79,709
|
76,448
|
90,184
|
78,280
|
78,900
|
Enterprise Value (EV)
1 |
29,915
|
36,026
|
30,685
|
34,606
|
26,068
|
34,633
|
P/E ratio
|
12.5
x
|
12.5
x
|
11.2
x
|
12.8
x
|
11.6
x
|
6.5
x
|
Yield
|
3.79%
|
5.39%
|
3.91%
|
4.81%
|
3.96%
|
-
|
Capitalization / Revenue
|
0.63
x
|
0.64
x
|
0.59
x
|
0.67
x
|
0.53
x
|
0.48
x
|
EV / Revenue
|
0.25
x
|
0.29
x
|
0.24
x
|
0.26
x
|
0.18
x
|
0.21
x
|
EV / EBITDA
|
3.29
x
|
3.25
x
|
2.47
x
|
3.12
x
|
2.09
x
|
2
x
|
EV / FCF
|
-20.3
x
|
-239
x
|
5.04
x
|
2.62
x
|
34.5
x
|
-4.59
x
|
FCF Yield
|
-4.93%
|
-0.42%
|
19.8%
|
38.2%
|
2.89%
|
-21.8%
|
Price to Book
|
0.58
x
|
0.59
x
|
0.54
x
|
0.62
x
|
0.52
x
|
0.5
x
|
Nbr of stocks (in thousands)
|
11,602
|
11,602
|
11,945
|
12,405
|
12,406
|
12,406
|
Reference price
2 |
6,600
|
6,870
|
6,400
|
7,270
|
6,310
|
6,360
|
Announcement Date
|
14/03/19
|
11/03/20
|
11/03/21
|
17/03/22
|
16/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
121,108
|
124,645
|
129,522
|
134,066
|
146,723
|
164,275
|
EBITDA
1 |
9,097
|
11,072
|
12,420
|
11,100
|
12,483
|
17,313
|
EBIT
1 |
6,493
|
7,910
|
9,422
|
8,198
|
9,337
|
13,589
|
Operating Margin
|
5.36%
|
6.35%
|
7.27%
|
6.11%
|
6.36%
|
8.27%
|
Earnings before Tax (EBT)
1 |
7,546
|
8,824
|
8,751
|
9,023
|
8,789
|
14,998
|
Net income
1 |
6,133
|
6,440
|
6,718
|
6,996
|
6,779
|
12,134
|
Net margin
|
5.06%
|
5.17%
|
5.19%
|
5.22%
|
4.62%
|
7.39%
|
EPS
2 |
528.6
|
547.8
|
569.1
|
570.1
|
546.0
|
978.0
|
Free Cash Flow
1 |
-1,475
|
-150.8
|
6,090
|
13,211
|
754.5
|
-7,542
|
FCF margin
|
-1.22%
|
-0.12%
|
4.7%
|
9.85%
|
0.51%
|
-4.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
49.03%
|
119.01%
|
6.04%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
90.66%
|
188.82%
|
11.13%
|
-
|
Dividend per Share
2 |
250.0
|
370.0
|
250.0
|
350.0
|
250.0
|
-
|
Announcement Date
|
14/03/19
|
11/03/20
|
11/03/21
|
17/03/22
|
16/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
46,661
|
43,683
|
45,762
|
55,578
|
52,212
|
44,267
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1,475
|
-151
|
6,090
|
13,211
|
755
|
-7,542
|
ROE (net income / shareholders' equity)
|
4.68%
|
4.79%
|
4.83%
|
4.85%
|
4.56%
|
7.83%
|
ROA (Net income/ Total Assets)
|
2.22%
|
2.6%
|
3.02%
|
2.56%
|
2.77%
|
3.85%
|
Assets
1 |
276,266
|
247,312
|
222,466
|
273,446
|
244,524
|
314,966
|
Book Value Per Share
2 |
11,420
|
11,682
|
11,759
|
11,814
|
12,112
|
12,841
|
Cash Flow per Share
2 |
4,021
|
3,783
|
4,088
|
4,529
|
3,981
|
3,599
|
Capex
1 |
3,276
|
1,517
|
1,772
|
1,419
|
5,338
|
3,848
|
Capex / Sales
|
2.7%
|
1.22%
|
1.37%
|
1.06%
|
3.64%
|
2.34%
|
Announcement Date
|
14/03/19
|
11/03/20
|
11/03/21
|
17/03/22
|
16/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.42% | 57.42M | | +2.08% | 3.62B | | -17.29% | 2.23B | | -9.08% | 1.94B | | +2.07% | 1.85B | | -1.75% | 1.67B | | -1.72% | 1.3B | | +7.87% | 1.23B | | -20.13% | 1.06B | | -3.74% | 997M |
Pesticide
|